Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
about
Mcl-1 suppresses abasic site repair following bile acid-induced hepatic cellular DNA damage.Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells.Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation.Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.
P2860
Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
@en
type
label
Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
@en
prefLabel
Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
@en
P2093
P2860
P1476
Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
@en
P2093
Ju-Sheng Lin
Qiong Chen
Zhao-Yu Liu
P2860
P2888
P304
P356
10.1007/S11596-016-1614-7
P577
2016-07-28T00:00:00Z
P6179
1011801771